Eventide Gilead Class I (ETILX)

Fund Assets	2.68B
Expense Ratio	1.16%
Min. Investment	$100,000
Turnover	n/a
Dividend (ttm)	0.64
Dividend Yield	1.19%
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Dec 13, 2024

Previous Close	55.04
YTD Return	5.16%
1-Year Return	9.56%
5-Year Return	36.34%
52-Week Low	42.04
52-Week High	56.59
Beta (5Y)	1.08
Holdings	76
Inception Date	Feb 2, 2010

About ETILX

The investment seeks to provide long-term capital appreciation. Normally, the fund invests primarily in a broad range of equity securities without limitation to market capitalization. It may invest without limitation in securities in companies domiciled outside the United States either directly or through ADRs. From time to time, the fund may invest a substantial portion of its assets in the stock of companies in one or more sectors of the economy, such as the technology, industrial, healthcare and life sciences sectors.

• Category: Mid-Cap Growth
• Stock Exchange: NASDAQ
• Ticker Symbol: ETILX
• Share Class: Class I
• Index: Russell MidCap Growth TR

Performance

ETILX had a total return of 9.56% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.38%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
ETGLX	Class N	1.36%
ETAGX	Class A	1.41%
ETCGX	Class C	2.16%

Top 10 Holdings

29.03% of assets

Name	Symbol	Weight
Verona Pharma plc	VRNA	4.78%
Guardant Health, Inc.	GH	3.90%
Toast, Inc.	TOST	3.11%
Xometry, Inc.	XMTR	2.99%
Old Dominion Freight Line, Inc.	ODFL	2.58%
Mirum Pharmaceuticals, Inc.	MIRM	2.57%
Trane Technologies plc	TT	2.55%
Waste Connections, Inc.	WCN	2.38%
Global-E Online Ltd.	GLBE	2.09%
RB Global, Inc.	RBA	2.08%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 13, 2024	$0.6441	Dec 16, 2024
Dec 15, 2022	$2.2812	Dec 16, 2022
Dec 16, 2021	$4.2652	Dec 17, 2021
Dec 17, 2020	$0.5114	Dec 17, 2020
Dec 17, 2019	$1.3176	Dec 17, 2019
Dec 18, 2018	$1.7132	Dec 18, 2018